AJI Cover
Frequency: Continuous
ISSN: 1553-619X (Print)
ISSN: 1558-3775 (Online)
Research Article Open Access

Lentinan Properties in Anticancer Therapy: A Review on the Last 12-Year Literature

Luca Vannucci1, Petr Sima1, Vaclav Vetvicka2 and Jiri Krizan1
  • 1 Institute of Microbiology v.v.i., Czech Academy of Sciences, Czech Republic
  • 2 University of Louisville, United States

Abstract

The effects of β-glucan in cancer are the most studied biological effects of β-glucan. From all available β-glucans, the most data are available on lentinan, mostly because it is used in clinical practice for over 20 years. Current review represent a state-of-the-art comprehensive review of knowledge obtained in last twelve years.

American Journal of Immunology
Volume 13 No. 1, 2017, 50-61

DOI: https://doi.org/10.3844/ajisp.2017.50.61

Submitted On: 15 November 2016 Published On: 12 April 2017

How to Cite: Vannucci, L., Sima, P., Vetvicka, V. & Krizan, J. (2017). Lentinan Properties in Anticancer Therapy: A Review on the Last 12-Year Literature. American Journal of Immunology, 13(1), 50-61. https://doi.org/10.3844/ajisp.2017.50.61

Open AccessCopyright: © 2017 Luca Vannucci, Petr Sima, Vaclav Vetvicka and Jiri Krizan. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • 5,256 Views
  • 3,417 Downloads
  • 50 Citations

Download

Keywords

  • Lentinan
  • Glucan
  • Cancer
  • Immunity